Esperion Therapeutics, Inc. (ESPR) Deep Dive Video
Summary
Esperion is inflecting from speculative biotech to cash-flowing cardiovascular platform as CLEAR Outcomes, guideline catalysts, and a triple-combo lifecycle strategy expand bempedoic acid into a mass-market LDL franchise.